药物诱导的胆固醇性肝脏疾病
Einar S Bjornsson1,2, Harshad C Devarbhavi3
1Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Hepatology (Baltimore, Md.)
|August 9, 2024
概括
药物诱导胆固醇症是一种具有挑战性的诊断,在了解检查点抑制剂和补充剂等新原因方面取得了进展. 本综述详细介绍了诊断方法,新的表型,如二次性硬化性胆管炎,以及遗传因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
- 胃肠病学 胃肠病学
背景情况:
- 胆固醇药物诱导性肝损伤 (DILI) 呈现出高酸酸酶的诊断挑战.
- 差异性诊断包括恶性瘤,胆固醇胆病,病毒性肝炎,败血症,胆炎和心力衰竭.
- 自2011年以来,最近的进展更新了有关药物诱导胆固醇病变表型,病因,危险因素和遗传学的知识.
研究的目的:
- 审查胆固醇性DILI的诊断方法.
- 描述新出现的临床表型,包括二次性硬化性胆道炎 (SSC) 和消失的胆道综合征.
- 提供有关胆固醇病的风险因素,遗传决定因素和病理生理学的概述.
主要方法:
- 文献综述,重点关注药物诱导胆固醇病的近期进展.
- 对诊断策略和临床表现的分析.
- 综合有关风险因素,遗传学和传送器病理生理学的信息.
主要成果:
- 检查点抑制剂和草药/食补充剂被确定为DILI诱导的SSC的原因.
- 新的遗传风险因素和对胆固醇损伤病原体的更清晰的理解已经出现.
- 二次性硬化性胆道炎和消失的胆道综合征代表了重要的临床表型.
结论:
- 胆固醇性DILI需要仔细的差异诊断,考虑到新的病因和表型.
- 了解遗传因素和传送机制对于定义胆固醇病变的病原性至关重要.
- 对管理策略和解决不确定性领域需要进一步研究.
相关概念视频
Diseases of the Liver and Gallbladder
496
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
496
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
610
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
610
Hepatic Drug Excretion: Influencing Factors
104
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
104
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436
Factors Influencing Drug Absorption: Disease States and Pharmacology
472
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
472


